Brainstorm Cell Therapeutics Inc. (BCLI)

Operating Cash Flow (Statement)

-$4.06M

TTM · Period ending: · USD

BCLI logo

BCLI Operating Cash Flow (Statement)

Latest reported-$4.06M
BCLI TTM Cash from Operations (-$9.70K → -$4.06M)
High-resolution chart · PNG

BCLI operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Brainstorm Cell Therapeutics Inc. Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-4,057,000
-6,664,000
-6,975,000
-7,283,000
-9,480,000
-7,661,000
-9,093,000
-11,330,000
-14,440,000
-19,535,000
-20,458,000
-21,821,000
-20,262,000
-19,618,000
-19,320,000
-20,180,000
-21,790,000
-20,985,000
-26,265,000
-28,335,000
-28,799,000
-29,132,000
-35,193,000
-30,893,000
-27,595,000
-25,441,000
-11,247,000
-11,692,000
-14,660,000
-11,097,000
-12,388,000
-11,600,000
-1,163,000
-2,848,000
-2,364,000
-625,000
-4,743,000
-4,519,000
-5,858,000
-5,953,000
-8,208,000
-8,452,000
-7,408,000
-8,124,000
-6,713,000
-6,033,000
-4,487,000
-4,088,000
-3,682,000
-3,775,000
-4,054,000
-3,123,000
-3,484,000
-2,840,000
-2,916,000
-2,710,000
-2,533,000
-2,914,000
-2,223,000
-2,299,000
-1,802,000
-1,527,000
-2,070,000
-1,834,000
-1,647,000
-1,180,000
-744,000
-578,000
-811,000
-1,230,000
-1,734,000
-1,862,000
-2,365,000
-2,191,936
-1,774,000
-1,677,906
-1,111,947
-1,216,970
-1,377,865
-1,545,676
-1,474,303
-1,252,281
-1,040,970
-1,180,537
-874,471
-700,778
-510,100
-30,755
-28,312
-15,436
-9,696
-4,423
-5,792
-7,012
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.